TY  - JOUR

T1  - 112: Laboratory parameters in adolescent patients aged 12-17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to Week 52: results from the phase 3 ECZTRA 6 trial

JO  - Journal of Investigative Dermatology

UR  - https://doi.org/10.1016/j.jid.2025.02.117

PY  - 2025/03/01

AU  - Paller A

AU  - Cork M

AU  - Hong C-H

AU  - Soong W

AU  - Schneider S

AU  - Lo H

AU  - Meldgaard Pedersen LR

AU  - Vacko E

AU  - Wollenberg A

ED  - 

DO  - DOI: 10.1016/j.jid.2025.02.117

PB  - Elsevier BV

VL  - 145

IS  - 3

SP  - e27

EP  - e27

Y2  - 2025/04/06

ER  -